June 5, 2017 | Israeli startup Belkin Laser, a portfolio company of Israel’s RAD Biomed accelerator, has secured $5 million in funding from Zicom Holdings, Rimonci Capital and the European Union (grant). The capital raised adds to the $1.5 million previously raised by the company. Belkin Laser develops a laser device for glaucoma patients who will receive short, efficient treatments, instead of the eye drops used today. Belkin Laser was founded in 2013 under a license agreement from Israel’s Sheba Medical Center and Tel Aviv University. Its product is based on Prof. Michael Belkin’s invention. [Photo: TobiasD]
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts
Israeli, US Companies Unite To Make More Milk From Mushrooms
March 27, 2024
Drone Startups Team Up To Boost Destroyer Of Enemy Craft
March 26, 2024
Israeli Investment Management Company Raises $100M
March 26, 2024
Facebook comments